Vaccine Implementation and Impact
About
Profiles
Research
Blog
Gallery
Who we are
We aim to be highly complementary and collaborative with other theme/s focusing on pathogens, AMR, and immunology / immunity, aiming NOT to replicate their areas of activity but to go for synergy.
The same would go for human experimental CHIM work.
What we (will) do:
- leveraging and building added scientific value from our activities and networks to attract and lead larger collaborative grants and consortia in these areas
- supporting training and capacity development
By: Felistas Kumwenda-Mwakiseghile, TyVAC Trial Coordinator, Malawi Liverpool Wellcome Trust & Fleesie Hubbard, M.S., International Regulatory Affairs Specialist, University of ...
